Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Prosperi

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Cancers|November 27, 2019
Thirty Years of Cancer Nanomedicine: Success, Frustration, and HopeLucia Salvioni, Maria Antonietta Rizzuto, Jessica Armida Bertolini, et al.
Chemical Communications (Cambridge, England)|November 15, 2013
One-pot phase transfer and surface modification of CdSe-ZnS quantum dots using a synthetic functional copolymerChiara Finetti, Miriam Colombo, Davide Prosperi, et al.
Chemical Communications (Cambridge, England)|August 8, 2014
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cellsSvetlana Avvakumova, Paola Fezzardi, Laura Pandolfi, et al.
Biomaterials Science|June 3, 2020
Dependence of nanoparticle-cell recognition efficiency on the surface orientation of scFv targeting ligandsSerena Mazzucchelli, Silvia Sommaruga, Maureen O'Donnell, et al.
BMC Biotechnology|September 7, 2014
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic mediaSilvia Sommaruga, Elisabetta Galbiati, Jesus Peñaranda-Avila, et al.
Nanomedicine (London, England)|August 16, 2019
Are nanotechnological approaches the future of treating inflammatory diseases?Maria Antonietta Rizzuto, Lucia Salvioni, Rany Rotem, et al.
Applied Microbiology and Biotechnology|May 4, 2011
Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cellsSilvia Sommaruga, Alessio Lombardi, Agnese Salvadè, et al.
Bioconjugate Chemistry|August 1, 2014
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cellsSvetlana Avvakumova, Elisabetta Galbiati, Laura Pandolfi, et al.
Bioconjugate Chemistry|March 6, 2015
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugatesElisabetta Galbiati, Marco Cassani, Paolo Verderio, et al.
Angewandte Chemie (International Ed. in English)|July 27, 2012
Protein-assisted one-pot synthesis and biofunctionalization of spherical gold nanoparticles for selective targeting of cancer cellsMiriam Colombo, Serena Mazzucchelli, Veronica Collico, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Cancers|November 27, 2019
Thirty Years of Cancer Nanomedicine: Success, Frustration, and HopeLucia Salvioni, Maria Antonietta Rizzuto, Jessica Armida Bertolini, et al.
Chemical Communications (Cambridge, England)|November 15, 2013
One-pot phase transfer and surface modification of CdSe-ZnS quantum dots using a synthetic functional copolymerChiara Finetti, Miriam Colombo, Davide Prosperi, et al.
Chemical Communications (Cambridge, England)|August 8, 2014
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cellsSvetlana Avvakumova, Paola Fezzardi, Laura Pandolfi, et al.
Biomaterials Science|June 3, 2020
Dependence of nanoparticle-cell recognition efficiency on the surface orientation of scFv targeting ligandsSerena Mazzucchelli, Silvia Sommaruga, Maureen O'Donnell, et al.
BMC Biotechnology|September 7, 2014
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic mediaSilvia Sommaruga, Elisabetta Galbiati, Jesus Peñaranda-Avila, et al.
Nanomedicine (London, England)|August 16, 2019
Are nanotechnological approaches the future of treating inflammatory diseases?Maria Antonietta Rizzuto, Lucia Salvioni, Rany Rotem, et al.
Applied Microbiology and Biotechnology|May 4, 2011
Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cellsSilvia Sommaruga, Alessio Lombardi, Agnese Salvadè, et al.
Bioconjugate Chemistry|August 1, 2014
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cellsSvetlana Avvakumova, Elisabetta Galbiati, Laura Pandolfi, et al.
Bioconjugate Chemistry|March 6, 2015
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugatesElisabetta Galbiati, Marco Cassani, Paolo Verderio, et al.
Angewandte Chemie (International Ed. in English)|July 27, 2012
Protein-assisted one-pot synthesis and biofunctionalization of spherical gold nanoparticles for selective targeting of cancer cellsMiriam Colombo, Serena Mazzucchelli, Veronica Collico, et al.
Pageof 13